
Wegovy cost: pen and pill prices
$349 a month is Wegovy's self-pay pen price, $25 with the savings card, or $50 under the Medicare Bridge. Pen and pill prices by dose, checked October 3, 2026.
How GLP-1 medications work, what the trials show, what they cost, and how to find a provider. All of it is grounded in FDA labels and peer-reviewed research.

$349 a month is Wegovy's self-pay pen price, $25 with the savings card, or $50 under the Medicare Bridge. Pen and pill prices by dose, checked October 3, 2026.

4 fixed Ozempic doses climb from 0.25 mg to a 2 mg weekly maximum for type 2 diabetes, never for weight loss, per the FDA label and this dosing chart.

11 of 28 people in our GLP-1 price survey would pay $149 a month but not $349 for the Wegovy pen. October 2026 Prolific survey, with FDA dates and data.

$299 is Lilly's self-pay Zepbound cost for 2.5 mg as of September 2026, $399 for 5 mg, $449 for 7.5 to 15 mg. Savings card, Medicare and insurance compared.

25 to 29% of adults on Zepbound had nausea vs 8% on placebo. Zepbound side effects by dose, how long they last, cancer risk, women, and Zepbound vs Wegovy.

6 injection strengths from 0.25 mg to 7.2 mg plus a 25 mg pill. The Wegovy dosage chart week by week, with missed-dose rules and the trial results for each.

44% of adults on Wegovy 2.4 mg had nausea in trials. Every side effect by dose, the 7.2 mg and pill data, how long each one lasts, and the warning signs.

3 approved sites for Ozempic injections: abdomen, thigh, and upper arm. How to rotate them, inject correctly, and avoid the lump that throws off absorption.

0 oral tirzepatide pills are FDA-approved. This guide covers the 2 GLP-1 pills approved instead, why tirzepatide resists absorption, and what the FDA says.

Stalled on Wegovy or Mounjaro? GLP-1 trials took 68 to 72 weeks to hit 15 to 21% loss, so a flat scale is usually timing, dose, or a real plateau, not failure.

A lipotropic injection is a shot of MIC (methionine, inositol, choline) plus B12 sold for fat loss. What each ingredient does, whether they work, and how they differ from GLP-1 skinny shots.

3 checks decide skinny-shot safety: the ingredient, your history, and the source. The FDA has warned about semaglutide products it has not reviewed for safety.

It depends entirely on which shot. Lipotropic and B12 skinny shots have almost no weight-loss evidence; prescription GLP-1 injections have some of the strongest trial data of any drug. Here is the honest difference.

94% of Ozempic matches human GLP-1. One weekly shot cuts appetite and blood sugar. STEP-1 lost 14.9% body weight at 68 weeks on the 2.4 mg Wegovy dose.

The gut effects match women. Three do not: muscle loss, testosterone, and erections. One ED database signal is 1.47% vs 0.32%. STEP-1 lean mass fell 9.7%.

GLP-1 side effects like nausea peak in the first weeks of each dose and ease by weeks 6–8. The week-by-week timeline, surgery precautions, and when to call.

2 oral GLP-1 pills are FDA-approved in 2026: the Wegovy pill and orforglipron. Oral tirzepatide is not. Here is what the 2026 trial data shows so far.

GLP-1 hair loss affects about 2.5% in trials (more with big weight loss) and mostly women. It is telogen effluvium from rapid loss — preventable and reversible.

Stop semaglutide and about two-thirds of lost weight returns within a year; tirzepatide withdrawal brought back 14% in SURMOUNT-4. Why, and what limits it.

GLP-1s work well for menopausal weight gain, and HRT may boost the response. But a GLP-1 can disrupt oral HRT absorption — why transdermal is the fix.